125 related articles for article (PubMed ID: 38538415)
1. Prospective validation of a machine learning model for applicator and hybrid interstitial needle selection in high-dose-rate (HDR) cervical brachytherapy.
Stenhouse K; Roumeliotis M; Ciunkiewicz P; Martell K; Quirk S; Banerjee R; Doll C; Phan T; Yanushkevich S; McGeachy P
Brachytherapy; 2024; 23(3):368-376. PubMed ID: 38538415
[TBL] [Abstract][Full Text] [Related]
2. Combined intracavitary and interstitial brachytherapy of cervical cancer using the novel hybrid applicator Venezia: Clinical feasibility and initial results.
Walter F; Maihöfer C; Schüttrumpf L; Well J; Burges A; Ertl-Wagner B; Mahner S; Belka C; Gallwas J; Corradini S
Brachytherapy; 2018; 17(5):775-781. PubMed ID: 29941345
[TBL] [Abstract][Full Text] [Related]
3. Early outcomes and impact of a hybrid IC/IS applicator for a new MRI-based cervical brachytherapy program.
Harkenrider MM; Surucu M; Harmon G; Mysz ML; Shea SM; Yacoub J; Goldberg A; Liotta M; Winder A; Potkul R; Roeske JC; Small W
Brachytherapy; 2018; 17(1):187-193. PubMed ID: 29089277
[TBL] [Abstract][Full Text] [Related]
4. Clinical use of the Utrecht applicator for combined intracavitary/interstitial brachytherapy treatment in locally advanced cervical cancer.
Nomden CN; de Leeuw AA; Moerland MA; Roesink JM; Tersteeg RJ; Jürgenliemk-Schulz IM
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1424-30. PubMed ID: 21669505
[TBL] [Abstract][Full Text] [Related]
5. Interstitial round needles should not be used for cervical cancer patient treated with intracavitary/ interstitial brachytherapy using a Venezia applicator : a case report.
Takagawa Y; Izumi S; Takahashi E; Kita M
BMC Womens Health; 2024 Apr; 24(1):249. PubMed ID: 38637783
[TBL] [Abstract][Full Text] [Related]
6. Outcomes and comparison of dosimetric parameters between intracavitary (Fletcher) and combined intracavitary/interstitial (Utrecht) brachytherapy in locally advanced cervical cancer.
Sarwar KA; Hussain S; Syed AS; Khan K; Maqsood T; Azeem T
Brachytherapy; 2024; 23(1):10-17. PubMed ID: 37813708
[TBL] [Abstract][Full Text] [Related]
7. 3T multiparametric MRI-guided high-dose-rate combined intracavitary and interstitial adaptive brachytherapy for the treatment of cervical cancer with a novel split-ring applicator.
Fredman E; Traughber B; Podder T; Colussi V; Zheng Y; Russo S; Herrmann K; Paspulati R; Waggoner S; Zanotti K; Nagel C; Nakayama J; Machtay M; Ellis R
Brachytherapy; 2018; 17(2):334-344. PubMed ID: 29097137
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric considerations when utilizing Venezia, Capri, Rotte double tandem, and tandem and ring with interstitial needles for the treatment of gynecological cancers with high dose rate brachytherapy.
Schnell E; Thompson S; Ahmad S; Herman TS; De La Fuente Herman T
Med Dosim; 2020 Spring; 45(1):21-27. PubMed ID: 31101569
[TBL] [Abstract][Full Text] [Related]
9. Needle-free cervical cancer treatment using helical multishield intracavitary rotating shield brachytherapy with the
Hopfensperger KM; Adams Q; Kim Y; Wu X; Xu W; Patwardhan K; Thammavong B; Caster J; Flynn RT
Med Phys; 2020 Jun; 47(5):2061-2071. PubMed ID: 32073669
[TBL] [Abstract][Full Text] [Related]
10. Technique adaptation, strategic replanning, and team learning during implementation of MR-guided brachytherapy for cervical cancer.
Skliarenko J; Carlone M; Tanderup K; Han K; Beiki-Ardakani A; Borg J; Chan K; Croke J; Rink A; Simeonov A; Ujaimi R; Xie J; Fyles A; Milosevic M
Brachytherapy; 2018; 17(1):86-93. PubMed ID: 29406125
[TBL] [Abstract][Full Text] [Related]
11. A practical guide to hybrid interstitial/intracavitary brachytherapy for locally-advanced cervical cancer.
Ladbury C; Harkenrider M; Taunk N; Fisher C; Mayadev J; Venkat P; Yashar C; Gaffney D; Beriwal S; Glaser S
Brachytherapy; 2023; 22(5):640-648. PubMed ID: 37481370
[TBL] [Abstract][Full Text] [Related]
12. Clinical feasibility of interstitial brachytherapy using a "hybrid" applicator combining uterine tandem and interstitial metal needles based on CT for locally advanced cervical cancer.
Liu ZS; Guo J; Lin X; Wang HY; Qiu L; Ren XJ; Li YF; Zhang BY; Wang TJ
Brachytherapy; 2016; 15(5):562-9. PubMed ID: 27474180
[TBL] [Abstract][Full Text] [Related]
13. Ring Versus Ovoids and Intracavitary Versus Intracavitary-Interstitial Applicators in Cervical Cancer Brachytherapy: Results From the EMBRACE I Study.
Serban M; Kirisits C; de Leeuw A; Pötter R; Jürgenliemk-Schulz I; Nesvacil N; Swamidas J; Hudej R; Lowe G; Hellebust TP; Menon G; Oinam A; Bownes P; Oosterveld B; De Brabandere M; Koedooder K; Langeland Marthinsen AB; Whitney D; Lindegaard J; Tanderup K;
Int J Radiat Oncol Biol Phys; 2020 Apr; 106(5):1052-1062. PubMed ID: 32007365
[TBL] [Abstract][Full Text] [Related]
14. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning, and dosimetric results.
Kirisits C; Lang S; Dimopoulos J; Berger D; Georg D; Pötter R
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):624-30. PubMed ID: 16690444
[TBL] [Abstract][Full Text] [Related]
15. Clinical feasibility of combined intracavitary/interstitial brachytherapy in locally advanced cervical cancer employing MRI with a tandem/ring applicator in situ and virtual preplanning of the interstitial component.
Fokdal L; Tanderup K; Hokland SB; Røhl L; Pedersen EM; Nielsen SK; Paludan M; Lindegaard JC
Radiother Oncol; 2013 Apr; 107(1):63-8. PubMed ID: 23452917
[TBL] [Abstract][Full Text] [Related]
16. Predicting which patients may benefit from the hybrid intracavitary+interstitial needle (IC/IS) applicator for advanced cervical cancer: A dosimetric comparison and toxicity benefit analysis.
Gonzalez Y; Giap F; Klages P; Owrangi A; Jia X; Albuquerque K
Brachytherapy; 2021; 20(1):136-145. PubMed ID: 33132073
[TBL] [Abstract][Full Text] [Related]
17. Intracavitary brachytherapy with additional Heyman capsules in the treatment of cervical cancer.
Scharl S; Hugo C; Weidenbächer CB; Bronger H; Brambs C; Kiechle M; Makowski MR; Combs SE; Schüttrumpf L
Arch Gynecol Obstet; 2023 Feb; 307(2):557-564. PubMed ID: 35639163
[TBL] [Abstract][Full Text] [Related]
18. A dosimetric comparison between applicators used for brachytherapy in carcinoma cervix - A single-institute prospective study.
Suryadevara A; Kumar MV; Vasundhara E; Alluri KR; Ahamed S; Guduru S
Indian J Cancer; 2018; 55(3):230-232. PubMed ID: 30693884
[TBL] [Abstract][Full Text] [Related]
19. Utrecht Interstitial Applicator Shifts and DVH Parameter Changes in 3D CT-based HDR Brachytherapy of Cervical Cancer.
Shi D; He MY; Zhao ZP; Wu N; Zhao HF; Xu ZJ; Cheng GH
Asian Pac J Cancer Prev; 2015; 16(9):3945-9. PubMed ID: 25987066
[TBL] [Abstract][Full Text] [Related]
20. Practical needle selection for Vienna-style applicators: improving therapeutic ratio in hybrid intracavitary-interstitial brachytherapy.
Martin DA; Taunk NK; Anamalayil S; Mangal V; Marcel J; Hubley E
J Contemp Brachytherapy; 2021 Oct; 13(5):533-540. PubMed ID: 34759978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]